N-terminal Pro-Brain Natriuretic Peptide, Kidney Disease and Outcome in Patients With Chronic Heart Failure

Journal of Heart and Lung Transplantation

Volumn 25, Issue 9, 2006, Pages 1135-1141

  Bruch, Christian ^a   Reinecke, Holger ^a   Stypmann, Jörg ^a   Rothenburger, Markus ^a   Schmid, Christof ^a   Breithardt, Günter ^a   Wichter, Thomas ^a   Gradaus, Rainer ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN;

ADULT; AGED; ANALYZER; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURVIVAL;

ADULT; AGED; CARDIAC OUTPUT, LOW; CHRONIC DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; LINEAR MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 33748209097     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.05.006     Document Type: Article

References (23)

1. Packer M., Coats A.J., Fowler M.B., et al., Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344 (2001) 1651-1658
2. McDonagh T.A., Cunningham A.D., Morrison C.E., et al. Left ventricular dysfunction, natriuretic peptides and mortality in an urban population. Heart 86 (2001) 21-26
3. Lainchbury J.G., Campbell E., Frampton C.M., Yandle T.G., Nicholls M.G., and Richards A.M. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. JAMA 42 (2003) 728-735
4. Gardner R.S., Ozalp F., Murday A.J., Robb S.D., and McDonagh T.A. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 24 (2003) 1735-1743
5. Tsutamoto T., Wada A., Maeda K., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96 (1997) 509-516
6. Hartmann F., Packer M., Coats A.J., et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 110 (2004) 1780-1786
7. Rothenburger M., Wichter T., Schmid C., et al. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. J Heart Lung Transplant 23 (2004) 1189-1197
8. Cameron S.J., and Green G.B. Cardiac biomarkers in renal disease: the fog is slowly lifting. Clin Chem 50 (2004) 2233-2235
9. National Kidney Foundation. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2 suppl 1 (2002) S46-S47
10. McAlister F.A., Ezekowitz J., Tonelli M., and Armstrong P.W. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109 (2004) 1004-1009
11. Dries D.L., Exner D.V., Domanski M.J., Greenberg B., and Stevenson L.W. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. JAMA 35 (2000) 681-689
12. Deng M.C., Breithardt G., and Scheld H.H. The Interdisciplinary Heart Failure and Transplant Program Munster: a 5-year experience. Int J Cardiol 50 (1995) 7-17
13. Ho K.K., Anderson K.M., Kannel W.B., Grossman W., and Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88 (1993) 107-115
14. Levey A.S., Bosch J.P., Lewis J.B., et al., Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130 (1999) 461-470
15. Shamim W., Francis D.P., Yousufuddin M., et al. Intraventricular conduction delay: a predictor of mortality in chronic heart failure?. Int J Cardiol 70 (1999) 171-178
16. Mancini D., Eisen H., Kussmaul W., et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83 (1991) 778-786
17. Xie G.Y., Berk M.R., Smith M.D., Gurley J.C., and DeMaria A.N. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. JAMA 24 (1994) 132-139
18. Eckardt K.U. Managing a fateful alliance: anaemia and cardiovascular outcomes. Nephrol Dial Transplant 20 suppl 6 (2005) 16-20
19. Ezekowitz J.A., McAlister F.A., and Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 107 (2003) 223-225
20. Apple F.S., Murakami M.M., Pearce L.A., and Herzog C.A. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 50 (2004) 2279-2285
21. McCullough P.A., Kuncheria J., and Mathur V.S. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure. Rev Cardiovasc Med 4 suppl 7 (2003) S3-S12
22. McCullough P.A., and Sandberg K.R. B-type natriuretic peptide and renal disease. Heart Fail Rev 8 (2003) 355-358
23. Anwaruddin S., Lloyd-Jones D.M., Baggish A., et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. JAMA 47 (2006) 91-97